A strong prognostic variable in endometrial carcinoma

Cancer

Volumn 79, Issue 5, 1997, Pages 944-951

  Kaleli, Semih ^a,b   Kösebay, Derin ^a   Beşe, Tugan ^a   Demirkiran, Fuat ^a   Öz, Utku A ^a   Arvas, Macit ^a   Aydinli, Kiliç ^a   Erkün, Engin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Murat Villa Apt ^*  (Turkey)

Author keywords

aneuploidy; DNA index; endometrial carcinoma; flow cytometry; prognostic factor; S phase fraction

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CELL CYCLE S PHASE; CELL FRACTIONATION; DNA CONTENT; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

AGE FACTORS; ANEUPLOIDY; CARCINOMA; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; PROGNOSIS; S PHASE; SURVIVAL ANALYSIS;

EID: 1842366066     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970301)79:5<944::AID-CNCR11>3.0.CO;2-2     Document Type: Article

References (37)

1. Piver MS, Marchetti DL. Endometrial carcinoma. In: Piver MS, editor. Manual of gynecologic oncology and gynecology. London: Little Brown, 1989.
2. Aydinli K, Bozkurt S, Erkun E, Atasu T. Kadmlarda genital kanser insidansi. Jinekoloji ve Obstetrik Dergisi 1987; 1:33-8.
3. Katayama KP, Jones HW. Chromosomes of atypical (adenomatous) hyperplasia and carcinoma of the endometrium. Am J Obstet Gynecol 1967;97:978-83.
4. Barlogie B, Göhde W, Johnston DA, Smallwood L, Schumann J, Drewinko B, et al. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res 1978;38:3333-9.
5. Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumors. J Clin Pathol 1984;37:961-74.
6. Atkin NB. Prognostic significance of ploidy level in human tumors I. Carcinoma of the uterus. J Natl Cancer Inst 1976;56:909-10.
7. Moberger B, Auer G, Forfslund G. The prognostic significance of DNA measurement in endometrial carcinoma. Cytometry 1985;5:430-6.
8. Ferenczy A. Cytodynamics of endometrial hyperplasia and neoplasia, part II: in vitro DNA histoautoradiography. Hum Pathol 1983;14:77-82.
9. Tase T, Toki T, Oikawa N, Wada Y, Yajima A, Suzuki M. Flow cytometric DNA analysis of human endometrial carcinoma. Tohoku J Exp Med 1985;146:429-37.
10. Iversen OE. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 1986;155:770-6.
11. Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB. Endometrial adenocarcinoma: a multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptor. Cancer 1986;58:1518-25.
12. Hedley DW, Frielander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985;6:327-33.
13. Quillamor RM, Furlong JW, Hoschner JA, Wynn RM. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma. Gynecol Obstet Invest 1988;26:332-7.
14. van der Putten HWHM, Baak JPA, Koenders TJM, Kurver PHJ, Stolk HG, Stolte LAM. Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma. Cancer 1989;63:1378-87.
15. Vindelov LL, Christensen IJ, Nissen WIA. Detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
16. Hiddemann W. Convention on nomenclature for DNA cytometry. Cytometry 1984;5:445-6.
17. FIGO news. Corpus cancer staging. Int J Gynaecol Obstet 1989;28:190.
18. Merkel DE, McGuire WL. Ploidy, proliferative activity and prognosis: DNA flow cytometry of solid tumors. Cancer 1990;65:1194-205.
19. Kallioniemi OP. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 1988; 9:164-9.
20. Haag D, Feichter G, Goerttler K, Kaufmann M. Influence of systematic errors on the evaluation of the S-phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas. Cytometry 1987;8:377-85.
21. Konski AA, Myles JL, Sawyer T, Nesiler J, Phibbs G, Leininger S, et al. Flow cytometric DNA content analysis of paraffin block embedded endometrial carcinomas. Int J Radiat Oncol Biol Phys 1991;21:1033-9.
22. Newburry R, Schmerck C, Goodspeed N, Fanning J, Glidewell DO, Evans M. DNA content as a prognostic factor in endometrial carcinoma. Obstet Gynecol 1990;76:251-7.
23. Takahashi Y. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues. Nippon Sanka Fujika Gakki Zasshi 1990;42:1339-44.
24. Kaleli S, Demirkiran F, Beşe T, Arvas M, Hekim N, Kösebay D, et al. Endometriyum adenokarsinomunda DNA içeriǧinin prognostik deǧeri. Jinekoloji ve Obstetrik Dergisi 1993;7:205-14.
25. Rosenburg P, Wingren S, Simonsen F, Stat O, Risberg B, Nordenskzold B. Flow cytometric measurements of DNA index and S phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator. Gynecol Oncol 1989;35:50-4.
26. Thornton JG, Ali S, O'Donovan P, Griffin N, Wells M, McDonald RR. Flow cytometric studies of ploidy and proliferative indices in the Yorkshire trial of adjuvant progestogen treatment of endometrial cancer. Br J Obstet Gynaecol 1993;100:253-61.
27. Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wieand HS, Podratz KC. Flow cytometric DNA analysis of stage I endometrial carcinoma. Gynecol Oncol 1989;34:317-22.
28. Podratz KC, Wilson TO, Gaffey TA, Cha SS, Katzmann A. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients. Obstet Gynecol 1993;168:1206-15.
29. Vecek N, Nola M, Marusic M, Babic D, Uzarevic B, Sabioncello A, et al. Tumor cell cycle in patients with stage I endometrial carcinoma. Gynecol Oncol 1994;53:38-43.
30. Kysela B, Siracky J, Redecha M, Bardos A. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma. Neoplasma 1990;37:489-95.
31. Friberg LG, Noren H, Delle U. Prognostic value of DNA ploidy and S phase fraction in endometrial cancer stage I and II: a prospective 5 years survival study. Gynecol Oncol 1994;53:64-9.
32. Geisinger KR, Kute TE, Marshall RB, Homesley HD, Morgan TM. Analysis of relationships of the ploidy and cell cycle kinetics to differentiation and the female sex steroid hormone receptors in adenocarcinoma of the endometrium. Am J Clin Pathol 1986;85:36-41.
33. Lindahl B, Alm P, Fern M, Killander D, Langstrom E, Norgren A, et al. Prognostic value of flow cytometrical DNA measurements in stage I-II endometrial carcinoma: correlations with steroid receptor concentration, tumor myometrial invasion and degree of differentiation. Anticancer Res 1987;7:7911-7.
34. Lindahl B, Ranstam J, Willen R. Five year survival rate in endometrial carcinoma stage I-II: influence of degree of tumor differentiation, age, myometrial invasion and DNA content. Br J Obstet Gynaecol 1994;101:621-5.
35. Naus GJ, DeVere R, Richart RM, Deitch AD. Predictive value of flow cytometric analysis of paraffin-embedded tissue in endometrial carcinoma. Lab Invest 1985;52:48.
36. Iversen OE, Utaker E, Skaarland E. DNA ploidy and steroid receptors as predictors of disease course in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 1988; 67:531-7.
37. Wagenius G, Strang P, Boman K, Tribukait B, Stendahl U. Residual myometrial invasion after intracavitary irradiation of endometrial adenocarcinoma stages I and II. Relations to DNA content and S-phase rate. In Vivo 1988;2:243-5.